Skip to main content

Table 2 Comparison of clinical characteristics at Day-1 and outcome between patients with tobramycin leakage and without

From: Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study

 

Without tobramycin

leakage

n= 17

With tobramycin

leakage

n= 83

P-value

Baseline

   

Age (years)

62 (49.5 to 69.5)

68 (59.0 to 76.0)

0.06

BMI

25.2 (22.7 to 27.7)

27.2 (24.1 to 29.3)

0.11

SOFA score

10 (7 to 11)

9 (7 to 12)

0.60

APACHE II score

25 (21 to 33)

27 (20 to 35)

0.61

APACHE II PM

59 (40 to 83)

61 (31 to 84)

0.78

SAPS II score

58 (46 to 66)

59 (44 to 73)

0.81

SAPS II PM

64 (37 to 78)

65 ((33 to 87)

0.79

APACHE III score

101 (70 to 124)

97 (73 to 132)

0.96

APACHE IV PM

61 (25 to 82)

56 (25 to 90)

0.87

Sepsis

5 (29.4)

27 (32.5)

1.00

CRP (mg/L)

3 (2 to 94)

37 (4 to 169)

0.06

Lowest MAP (mmHg)

78 (65 to 99)

79 (61 to 94)

0.90

Dopamine dose (μg/kg/minute)

3.3 (2.2 to 5.9)

6.7 (2.8 to 17.2)

0.02

Noradrenalin dose (μg/kg/minute)

0.00 (0.00 to 0.00)

0.00 (0.00 to 0.05)

0.09

Fluid balance (ml)

3,450 (548 to 4,646)

3,074 (1,323 to 4,528)

0.99

Lowest PO2 mmHg

75 (61.0 to 83.5)

70 (60.8 to 82.0)

0.53

PF ratio (mmHg/fraction)

206 (125 to 276)

206 (156 to 300)

0.72

Lowest pH

7.21 (7.08 to 7.27)

7.21 (7.09 to 7.29)

0.68

Creatinine before hospital admission (μmol/L)

83 (64.0 to 101.5)

77 (56.0 to 96.5)

0.43

Creatinine admission (μmol/L)

98 (75 to 129)

99 (69 to 144)

0.92

Creatinine d2 (μmol/L)

87 (59 to 101)

95 (70 to 144)

0.24

Urinary output (ml)

3,645 (1,893 to 4,608)

2,150 (1,092 to 3,585)

0.05

Urinary output (ml/kg/h)

1.8 (1.07 to 2.85)

1.0 (0.55 to 1.88)

0.04

RIFLE 1,2,3 c

   

0

13 (77)

45 (56)

0.40

1

2 (12)

11 (14)

 

2

1 (6)

14 (17)

 

3

1 (6)

11 (14)

 

Bilirubin (μmol/L)

6 (4 to 13)

9 (6 to 17)

0.07

Hemoglobin (mmol/L)

7.5 (5.5 to 8.8)

6.8 (5.9 to 8.2)

0.34

Platelets (giga)

214 (165 to 276)

200 (148 to 300)

0.75

Gastric retention (ml/day)

450 (215.0 to 777.0)

250 (112.5 to 660.0)

0.18

Outcome

   

CVVH during ICU admission

3 (18%)

22 (27%)

0.55

Duration mechanical ventilation (h)

42 (32 to 76)

62 (25 to 114)

0.72

LOS ICU (days)

2.2 (1.8 to 4.0)

3.4 (2.0 to 6.2)

0.29

Creatinine hospital discharge (μmol/L)

99 (59 to 129)

82 (58 to 147)

0.69

Creatinine hospital discharge/ creatinine pre-admission

1.13 (1.02 to 1.32)

1.16 (1.00 to 1.54)

0.81

Mortality hospital n (%)

6 (35)

25 (30)

0.46

  1. Values in median (interquartile range). APACHE, Acute Physiology and Chronic Health Evaluation; CVVH, continuous venovenous hemofiltration; PF, ratio PaO2 (mmHg)/inspiratory oxygen (fraction); PM, predicted mortality; SAPS, Simplified Acute Physiology Score; SOFA, Sequential organ failure score. a within two hours of ICU admission, b creatinine of the chronic dialysis patients not included, c RIFLE acronym for risk of acute kidney injury: Risk = 1, Injury = 2, Failure = 3